Revvity, Inc.
Revvity, Inc. (RVTY) is a healthcare company providing diagnostics, life sciences tools, and services, with its strongest political signal being active congressional trading by six politicians aligned with its lobbying, including Rep. Ro Khanna (D-CA) with $120,007.5 in buys and 29 trades.
BusinessWhat RVTY does
Revvity operates in the healthcare sector, focusing on diagnostics, life sciences, and applied markets, generating revenue from the sale of instruments, reagents, software, and services for research, clinical, and applied markets. Its business model involves providing tools and solutions for drug discovery, diagnostics, and environmental testing.
12 months past · 3 months futureRVTY activity timeline
Executive Branch ConflictsRVTY held by Trump-administration officials
Lifetime Government AwardsRVTY federal contracts
RVTY doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Politicians Trading RVTYMembers of Congress with recent RVTY positions
Congressional TradesWho in Congress is trading RVTY
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting RVTYLive legislation impacting this stock
Political ProfileWhere RVTY sits in Washington
[object Object]
STRUCTURAL: Six politicians (3R, 3D) show lobbying alignment with $30,000 each in lobbying_amount and committee matches across healthcare, armed services, and science committees. EVIDENTIARY: Active congressional trading with 55 total ticker trades among them, including recent purchases in 2025-2026 per top congressional traders. Net: Strong bipartisan engagement with evidentiary trading activity, though no federal contracts or insider buys.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
FDA Medical Device Product policiesFDA"get_political_influence.lobbying[0].specific_issues includes 'FDA Medical Device Product policies'"
Regulatory opportunities
-
Diagnostic test reimbursement and policies, including newborn screening and pandemic preparednessCMS, FDA"get_political_influence.lobbying[0].specific_issues includes 'Diagnostic test reimbursement and policies', 'Proposals related to newborn screening', 'Proposals related to pandemic preparedness'"
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for RVTY
Live signals + predictions for RVTY — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades RVTY
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord